Yingtai Medical announced that the board of directors of the company reviewed and approved the proposed issuance of A-shares and related matters. It is proposed to publicly issue no more than 37.2706 million A-shares, accounting for no more than 15% of the total share capital after issuance, and may be over-allotted by no more than 15% of the shares issued. The sponsor is Cathay Pacific Haitong Securities. The release plans to raise 1,800 billion yuan for projects such as medical device industrial parks, expansion, R&D, marketing network construction, and loan repayment. At the same time, the board of directors reviewed and approved the draft articles of association and governance system applicable after A-share listing, as well as revising the H share incentive trust plan to allow trustees to trade H shares through on-market or off-market transactions. The matters relating to A-shares mentioned above are subject to approval by the Extraordinary General Meeting of Shareholders and the Supervisory Authority.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.